Details for Patent: 11,478,488
✉ Email this page to a colleague
Which drugs does patent 11,478,488 protect, and when does it expire?
Patent 11,478,488 protects SEGLENTIS and is included in one NDA.
This patent has sixty-seven patent family members in thirty-four countries.
Summary for Patent: 11,478,488
| Title: | Co-crystals of tramadol and coxibs |
| Abstract: | The present invention relates to co-crystals of tramadol and co-crystal formers selected from NSAIDs/coxibs, processes for preparation of the same and their uses as medicaments or in pharmaceutical formulations, more particularly for the treatment of pain. |
| Inventor(s): | Plata-Salaman Carlos-Ramón, Tesson Nicolas |
| Assignee: | ESTEVE PHARMACEUTICALS, S.A. |
| Application Number: | US16720574 |
|
Patent Claim Types: see list of patent claims |
Drugs Protected by US Patent 11,478,488
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kowa Pharms | SEGLENTIS | celecoxib; tramadol hydrochloride | TABLET;ORAL | 213426-001 | Oct 15, 2021 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | A METHOD FOR TREATMENT OF PAIN IN ADULTS USING TRAMADOL HYDROCHLORIDE AND CELECOXIB | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,478,488
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 079008 | ⤷ Sign Up | |||
| Australia | 2009304235 | ⤷ Sign Up | |||
| Australia | 2010306168 | ⤷ Sign Up | |||
| Brazil | 112012005011 | ⤷ Sign Up | |||
| Brazil | PI0920358 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
